CDK8/19-IN-2
Product Specifications
CAS Number
3024381-54-9
Target
STAT, CDK
Related Pathways
Cell Cycle/Checkpoint, Stem Cells, JAK/STAT signaling
Bioactivity
CDK8/19-IN-2 (compound 12) is a potent inhibitor of cyclin-dependent kinases 8 and 19 (CDK8 and CDK19), exhibiting IC 50 values of 2.08 nM and 2.49 nM, respectively. This orally active compound is applicable in the research of acute myeloid leukemia (AML), breast cancer, and lymphoma.
Smiles
FC(F)C=1C(Br)=C(Br)C=C2C1N=C(N2C3CCOCC3)N4CCNCC4
Molecular Formula
C17H20Br2F2N4O
Molecular Weight
494.17
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6298567-01 0.1 mL
FBXW8, ID (FBXW8, FBW6, FBW8, FBX29, FBXO29, FBXW6, F-box/WD repeat-containing protein 8, F-box and WD-40 domain-containing protein 8, F-box only protein 29) (MaxLight 550)
Sign In for Pricing
View Details MBS6298567-02 5x 0.1 mL
FBXW8, ID (FBXW8, FBW6, FBW8, FBX29, FBXO29, FBXW6, F-box/WD repeat-containing protein 8, F-box and WD-40 domain-containing protein 8, F-box only protein 29) (MaxLight 550)
Sign In for Pricing
View Details 
TRV-0018953-01 10 µg
Eukaryotic Insulin Like Growth Factor Binding Protein 4 (IGFBP4)
Sign In for Pricing
View Details TRV-0018953-02 50 µg
Eukaryotic Insulin Like Growth Factor Binding Protein 4 (IGFBP4)
Sign In for Pricing
View Details TRV-0018953-03 100 µg
Eukaryotic Insulin Like Growth Factor Binding Protein 4 (IGFBP4)
Sign In for Pricing
View Details TRV-0018953-04 200 µg
Eukaryotic Insulin Like Growth Factor Binding Protein 4 (IGFBP4)
Sign In for Pricing
View Details